CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

Published:2020-03 Issue:3 Volume:37 Page:340-353.e6
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Salvador-Barbero Beatriz,Álvarez-Fernández Mónica,Zapatero-Solana Elisabet,El Bakkali Aicha,Menéndez María del Camino,López-Casas Pedro P.,Di Domenico Tomas,Xie Tao,VanArsdale Todd,Shields David J.,Hidalgo Manuel,Malumbres Marcos

Funder

Ministerio de Ciencia e Innovación

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference66 articles.

1. HTSeq–a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

2. The novel cyclin-dependent kinase 4/6 inhibitor ribociclib (LEE011) alone and in dual-targeting approaches demonstrates antitumoral efficacy in neuroendocrine tumors in vitro;Aristizabal Prada;Neuroendocrinology,2018

3. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug Discov.,2015

4. Genomic analyses identify molecular subtypes of pancreatic cancer;Bailey;Nature,2016

5. Model organoids provide new research opportunities for ductal pancreatic cancer;Boj;Mol. Cell Oncol.,2016

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response;Translational Oncology;2024-11

2. The mechanisms of diseases and global approaches;Folia Pharmacologica Japonica;2024-09-01

3. Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer;Cell Death & Disease;2024-08-01

4. Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells;Cancers;2024-07-30

5. Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis;Cell Reports;2024-07